HONEYWELL INTERNATIONAL INC
For the period ended Dec 31, 2025. Filed Feb 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 17, 2026
HON$229.00+4.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Cash Flows
| TABLE OF CONTENTS | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA |
|---|
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 · 2024 · 2023 | |||
| (Dollars in millions) | |||
| Cash flows from operating activities | |||
| Net income | $4,772 | $5,740 | $5,672 |
| Less: Net income from discontinued operations | 304 | 745 | 743 |
| Net income from continuing operations | 4,468 | 4,995 | 4,929 |
| Adjustments to reconcile net income from continuing operations to net cash provided by operating activities | |||
| Depreciation | 546 | 493 | 490 |
| Amortization | 842 | 659 | 514 |
| Loss (gain) on sale of non-strategic businesses and assets | 18 | 1 | (5) |
| Impairment of goodwill | 724 | — | — |
| Impairment of assets held for sale | 270 | 219 | — |
| Repositioning and other (gains) charges | (167) | 239 | 844 |
| Net payments for repositioning and other charges | (378) | (470) | (445) |
| NARCO Buyout payment | — | — | (1,325) |
| Resideo indemnification and reimbursement agreement termination payment | 1,590 | — | — |
| Asbestos liabilities divestiture payment | (1,428) | — | — |
| Pension and other postretirement income | (396) | (477) | (408) |
| Pension and other postretirement benefit payments | (20) | (32) | (35) |
| Stock compensation expense | 196 | 189 | 197 |
| Deferred income taxes | 18 | (229) | 189 |
| Other | 144 | (191) | (534) |
| Changes in assets and liabilities, net of the effects of acquisitions and divestitures | |||
| Accounts receivable | (825) | (129) | 67 |
| Inventories | (636) | (286) | (549) |
| Other current assets | (233) | (111) | 224 |
| Accounts payable | 724 | 78 | 444 |
| Accrued liabilities | 1,325 | 233 | 270 |
| Income taxes | (707) | (69) | (408) |
| Net cash provided by operating activities from continuing operations | 6,075 | 5,112 | 4,459 |
| Net cash provided by operating activities from discontinued operations | 333 | 985 | 881 |
| Net cash provided by operating activities | 6,408 | 6,097 | 5,340 |
| Cash flows from investing activities | |||
| Capital expenditures | (986) | (871) | (741) |
| Proceeds from disposals of property, plant and equipment | 31 | — | 43 |
| Increase in investments | (1,503) | (1,077) | (560) |
| Decrease in investments | 1,469 | 870 | 971 |
| (Payments) receipts from settlements of derivative contracts | (399) | 94 | 6 |
| Cash paid for acquisitions, net of cash acquired | (2,211) | (8,880) | (718) |
| Proceeds from sales of businesses, net of fees paid | 1,157 | — | 4 |
| Net cash used for investing activities from continuing operations | (2,442) | (9,864) | (995) |
| Net cash used for investing activities from discontinued operations | (269) | (293) | (298) |
| Net cash used for investing activities | (2,711) | (10,157) | (1,293) |
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (Dollars in millions) | |||
| Cash flows from financing activities | |||
| Proceeds from issuance of commercial paper and other short-term borrowings | 24,297 | 13,838 | 12,991 |
| Payments of commercial paper and other short-term borrowings | (22,815) | (11,578) | (13,663) |
| Proceeds from issuance of common stock | 237 | 537 | 196 |
| Proceeds from issuance of long-term debt | 4,035 | 10,408 | 2,986 |
| Payments of long-term debt | (2,909) | (1,812) | (1,731) |
| Repurchases of common stock | (3,804) | (1,655) | (3,715) |
| Cash dividends paid | (2,976) | (2,902) | (2,855) |
| Pre-separation funding | 1,962 | — | — |
| Spin-off cash | (449) | — | — |
| Other | 469 | 3 | 28 |
| Net cash (used for) provided by financing activities | (1,953) | 6,839 | (5,763) |
| Effect of foreign exchange rate changes on cash and cash equivalents | 176 | (137) | 14 |
| Net increase (decrease) in cash and cash equivalents | 1,920 | 2,642 | (1,702) |
| Cash and cash equivalents at beginning of period | 10,567 | 7,925 | 9,627 |
| Cash and cash equivalents at end of period | $12,487 | $10,567 | $7,925 |
58 Honeywell International Inc.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.